Marilynn Marchione

Latest in Home
Ep409
Electronics Giant to Build 'AI Supercomputer' Factories in Texas
August 25, 2025
Ep233
Factory Makes Car Every 76 Seconds; Corvette Opens Like Jet; AI Attacks Start | Today in Manufacturing Ep. 233
August 25, 2025
Ep408
Toto Expands U.S. Toilet Production, Leans Heavily on Automation to Make Luxury Loos
August 22, 2025
Ready-made cardboard boxes are moved in stacks along an automated packaging line.
International Paper to Close 2 Georgia Mills, Cut 1,100 Jobs
August 22, 2025
Related Stories
In this Dec. 18, 2019, photo, Toyota's human-shaped T-HR3 robot is remotely controlled by its staff member during a demonstration in Tokyo.
News
Toyota Upgrades its Humanoid Robot
Opengraph Fb
Manufacturing
Milwaukee Tool Plans to Build New Campus, Add 870 Jobs
Louie walks with the assistance of a cart UW-Madison students modified for him.
Medical
Engineering Students Modify Cart for Dog Born Without Front Legs
Batman
Military
Startup Debuts Rope-Firing Weapon
More from Marilynn Marchione
A rendering of packaging and vials containing HIV treatment Cabenuva.
Medical
FDA Approves 1st Long-Acting HIV Drug Combo
The two-shot combination is expected to make it easier for people to stay on track with their medicines.
January 22, 2021
Food and Drug Administration campus in Silver Spring, Md., Oct. 14, 2015.
Medical
Panel Urges Rejection of Experimental Alzheimer's Drug
Advisers concluded there wasn’t enough evidence that the drug slowed the disease.
November 9, 2020
A Biogen scientist works on Alzheimer’s disease research in a laboratory at the drugmaker’s headquarters in Cambridge, Mass., Dec. 12, 2019.
Medical
FDA Panel Reviews 1st New Alzheimer's Drug in 2 Decades
One of the biggest drug decisions in decades is looming.
November 6, 2020
Scientists work with a bioreactor at a Regeneron Pharmaceuticals facility in New York state.
Medical
2nd COVID-19 Antibody Drug Study Has Setback
Independent monitors recommended halting enrollment of the most severely ill patients due to a potential safety problem.
November 2, 2020
Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead U.S. manufacturing site, March 2020.
Medical
FDA Approves First COVID-19 Drug
Remdesivir cut the time to recovery by an average of five days in a large study.
October 23, 2020
An undated image from video provided by Regeneron Pharmaceuticals shows vials inspected at the company's facilities in New York state, Oct. 2, 2020.
Medical
Antibody Drugs Are No Cure but Seem Promising for COVID-19
Eli Lilly and Regeneron have asked the Food and Drug Administration for emergency authorization.
October 9, 2020
Researchers prepare cells to produce possible COVID-19 antibodies for testing in a laboratory in Indianapolis, May 2020.
Medical
Lilly Seeks Emergency Use of Antibody Drug for COVID-19
Early results from a study that suggested the drug reduced symptoms, the amount of the virus, hospitalizations and ER visits.
October 7, 2020
A health care worker administers a COVID-19 test at the Martin Luther King, Jr. Clinica Campesina Health Center in Homestead, Fla., July 6, 2020.
Medical
Drug Shows Promise in 1st Largely Minority COVID-19 Study
Tocilizumab, sold as Actemra and RoActemra, treats rheumatoid arthritis and other diseases.
September 21, 2020
Eli Lilly & Co. corporate headquarters in Indianapolis, April 26, 2017.
Medical
Antibody Drug May Cut COVID-19 Hospitalizations
Eli Lilly said the results are an encouraging “proof of principle” as it and other studies continue.
September 16, 2020
A researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis, May 2020.
Medical
Companies Test COVID-19 Antibody Drugs
With a vaccine still months off, companies are rushing to test what may be the next best thing.
August 12, 2020
A pharmacist holds a bottle of hydroxychloroquine in Oakland, Calif., April 6, 2020.
Medical
Study on Malaria Drug for Coronavirus Retracted
Independent reviewers were not able to verify information that’s been widely questioned by other scientists.
June 5, 2020
A pharmacist holds a bottle of hydroxychloroquine in Oakland, Calif., April 6, 2020.
Medical
Malaria Drug Fails to Prevent COVID-19 in Rigorous Study
Hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.
June 4, 2020
Gilead Sciences headquarters in Foster City, Calif., April 30, 2020.
Medical
Gilead Says Drug Helped Moderately Ill Coronavirus Patients
Remdesivir is the only treatment that’s been shown in a rigorous experiment to help fight the virus.
June 2, 2020
A bicyclist pedals past an entrance to a Moderna building, Cambridge, Mass., May 18, 2020.
Medical
Early Vaccine Results Encouraging, Company Says
Study volunteers had antibodies similar to those seen in people who have recovered from COVID-19.
May 19, 2020
Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site, March 2020.
Medical
US OKs 1st Drug Shown to Help Virus Recovery
The FDA cleared Gilead Science’s intravenous drug for hospitalized patients with "severe disease."
May 4, 2020